Founded in 1988, Piramal Pharma Limited is a leading global pharmaceutical company that offers a comprehensive range of services and products covering the entire drug lifecycle. The company operates through its three core businesses - Pharma Solutions, Critical Care, and Consumer Products. Piramal Pharma's Pharma Solutions business provides contract development and manufacturing services (CDMO) to over 100 customers across the globe. With a strong focus on innovation and quality, it develops and manufactures active pharmaceutical ingredients (APIs), complex intermediates, custom development & commercial manufacturing solutions for various applications including oncology, cardiovascular diseases, central nervous system disorders among others. In addition to this, Piramal's Critical Care business specializes in hospital generics as well as proprietary products in the areas of anesthesia and pain management. They are known for their high-quality formulations which cater to critical care therapies with an emphasis on inhalation anesthesia and intrathecal therapy. Further strengthening its presence in healthcare industry, Piramal also has Consumer Products division offering a wide range of consumer healthcare products such as OTC medicines; wellness supplements etc., catering to diverse markets globally. Piramal Pharma stands out from its competitors due to its commitment towards innovation-driven growth strategies coupled with robust R&D capabilities aimed at developing novel therapeutics. It has also made significant investments in cutting-edge technology platforms like continuous flow chemistry which enables efficient production processes resulting into faster time-to-market delivery for drugs alongwith cost savings. Moreover,Piramal’s strategic alliances with several reputed organizations have facilitated them expand their product portfolio while leveraging each other’s expertise bringing innovative offerings for patients worldwide.Piramals partnership with companies like Allergan,Carnegie Mellon University,Ash Stevens Inc.(a U.S.-based CDMO) speaks volumes about their collaborative approach reinforcing their position within pharmceutical landscape This relentless pursuit of excellence combined with a customer-centric approach has enabled Piramal Pharma Ltd.to emerge as one of the most trusted names in the global pharma industry,promising superior outcomes that matter.To further strengthen its foothold,the company aims continualy invest resources towards expanding capacity enhancing operational efficiencies focusing key therapeutic segments characterized by unmet medical needs.